title: NMR reporter screening for the detection of high-affinity ligands.
authors.affiliation: Novartis Pharma AG, P.O. Box, 4002 Basel, Switzerland. wolfgang.jahnke@pharma.novartis.com
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Jahnke
authors.forename: Philipp
authors.initials: P
authors.lastname: Floersheim
authors.forename: Christian
authors.initials: C
authors.lastname: Ostermeier
authors.forename: Xiaolu
authors.initials: X
authors.lastname: Zhang
authors.forename: Rene
authors.initials: R
authors.lastname: Hemmig
authors.forename: Konstanze
authors.initials: K
authors.lastname: Hurth
authors.forename: Doncho P
authors.initials: DP
authors.lastname: Uzunov
mesh_terms: D015096:3-Hydroxysteroid Dehydrogenases / Q000737:chemistry*; D045002:3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); D001572:Benzofurans / Q000737:chemistry*; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006801:Humans; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D011506:Proteins / Q000737:chemistry*
chemical_list: D001572:Benzofurans; D004791:Enzyme Inhibitors; D008024:Ligands; D011506:Proteins; C469295:2-acetylbenzofuran; D015096:3-Hydroxysteroid Dehydrogenases; D045002:3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)